Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.425, 2003-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
IV vancomycin to oral linezolid switch potentially cost saving
Inpharma, Vol. 1, Iss. 1400, 2003-01 ,pp. :
Access to resources
Recommend
Switch from IV to oral quinolones cost saving for Spanish hospital
Inpharma, Vol. 1, Iss. 1480-1481, 2005-01 ,pp. :
Oral linezolid cost saving in MRSA-related infections
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 482, 2005-01 ,pp. :
Moxifloxacin IV-to-oral switch proves cost effective in patients with CAP
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 368, 2002-01 ,pp. :
Moxifloxacin IV-to-oral switch proves cost effective in patients with CAP
Inpharma, Vol. 1, Iss. 1343, 2002-01 ,pp. :